Triple antiviral drug shows early promise in Covid-19 trial

The trial, which involved 127 patients, compared those given the combination drug - made up of the HIV medicine lopinavir–ritonavir, the hepatitis drug ribavirin, and the multiple sclerosis treatment interferon beta.

from Hindustan Times - world https://ift.tt/2SNNOo9